Cowen And Company, LLC Sio Gene Therapies Inc. Transaction History

Cowen And Company, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.07 - $2.89 $46,575 - $65,025	-22,500 Closed	0 $0
Q1 2021 May 04, 2021	BUY	$2.34 - $3.44 $8,189 - $12,040	3,500 Added 18.42%	22,500 $59,000
Q4 2020 Feb 08, 2021	BUY	$1.91 - $5.63 $36,290 - $106,970	19,000 New	19,000 $53,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.